1 |
Akar U, Chaves-Reyez A, Barria M, et al (2008). Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells. Autophagy, 4, 669.
|
2 |
Albert JM, Gonzalez-Angulo AM, Guray, M, et al (2010). Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a, bN0 breast cancer. Int J Radiation Oncol Biol Physics, 77, 1296-302.
DOI
ScienceOn
|
3 |
Brandt S, Kopp A, Grage B, Knabbe C (2003). Effects of tamoxifen on transcriptional level of transforming growth factor beta (TGF- ) isoforms 1 and 2 in tumor tissue during primary treatment of patients with breast cancer. Anticancer Res, 23, 223-9.
|
4 |
Cheng ASL, Jin VX, Fan M, et al (2006). Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor- responsive promoters. Molecular Cell, 21, 393-404.
DOI
|
5 |
Chrzan P, Skokowski J, Karmolinski A, et al (2001). Amplification of c-myc gene and overexpression of c-Myc protein in breast cancer and adjacent non-neoplastic tissue. Clin Biochem, 34, 557-62.
DOI
|
6 |
Dang CV (1999). c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol, 19, 1-11.
DOI
|
7 |
Dawson S, Makretsov N, Blows F, et al (2010). BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received. Br J Cancer, 103, 668-75.
DOI
ScienceOn
|
8 |
Drabsch Y, Hugo H, Zhang R, et al (2007). Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells. Proc Natl Acad Sci U S A, 104, 13762-7.
DOI
|
9 |
Formby B, Wiley T, et al (1998). Progesterone inhibits growth and induces apoptosis in breast cancer cells: inverse effects on Bcl-2 and p53. Ann Clin Lab Sci, 28, 360-9.
|
10 |
Ha SA, Shin SM, Namkoong H, et al (2004). Cancer-associated expression of minichromosome maintenance 3 gene in several human cancers and its involvement in tumorigenesis. Clin Cancer Res, 10, 8386-95.
DOI
|
11 |
Huang da W, Sherman BT, Lempicki RA (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc, 4, 44-57.
DOI
|
12 |
Jiang C, Xuan Z, Zhao F, Zhang MQ (2007). TRED: a transcriptional regulatory element database, new entries and other development. Nucleic Acids Res 35, D137-40.
DOI
|
13 |
Kauraniemi P, Hedenfalk I, Persson K, et al (2000). MYB oncogene amplification in hereditary BRCA1 breast cancer. Cancer Res, 60, 5323-8.
|
14 |
Klinge CM (2000). Estrogen receptor interaction with coactivators and co-repressors. Steroids, 65, 227-51.
DOI
|
15 |
Lefebvre C, Rajbhandari P, Alvarez MJ, et al (2010). A human B-cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centers. Mol Syst Biol, 6, 377.
|
16 |
Muller A, Kohrt HEK, Cha S, et al (2011). Long-term outcome of patients with metastatic breast cancer treated with high-dose chemotherapy and transplantation of purified autologous hematopoietic stem cells. Biol Blood Marrow Transplant, 18, 125-33.
|
17 |
Li C, Briggs MR, Ahlborn TE, et al (2001). Requirement of Sp1 and estrogen receptor interaction in -estradiolmediated transcriptional activation of the low density lipoprotein receptor gene expression. Endocrinology, 142, 1546-53.
DOI
|
18 |
Matys V, Fricke E, Geffers R, et al (2003). TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res, 31, 374-8.
DOI
ScienceOn
|
19 |
Migliaccio A, Piccolo D, Castoria G, et al (1998). Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J, 17, 2008-18.
DOI
ScienceOn
|
20 |
Pacek M, Walter JC (2004). A requirement for MCM7 and Cdc45 in chromosome unwinding during eukaryotic DNA replication. EMBO J, 23, 3667-76.
DOI
|
21 |
Pathiraja TN, Shetty PB, Jelinek J, et al (2011). Progesterone receptor isoform-specific promoter methylation: association of PRA promoter methylation with worse outcome in breast cancer patients. Clin Cancer Res, 17, 4177-86.
DOI
|
22 |
Pocsfalvi G, Votta G, De Vincenzo A, et al (2011). Analysis of secretome changes uncovers an autocrine/paracrine component in the modulation of cell proliferation and motility by c-Myc. J Proteome Res, 10, 5326-37.
DOI
|
23 |
Real PJ, Sierra A, De Juan A, et al (2002). Resistance to chemotherapy via Stat3-dependent overexpression of Bcl- 2 in metastatic breast cancer cells. Oncogene, 21, 7611-8.
DOI
|
24 |
Smyth GK (2004). Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol, 3, Article3.
|
25 |
Ren B, Yu G, Tseng GC, et al (2006). MCM7 amplification and overexpression are associated with prostate cancer progression. Oncogene, 25, 1090-8.
DOI
|
26 |
Shannon P, Markiel A, Ozier O, et al (2003). Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res, 13, 2498-504.
DOI
ScienceOn
|
27 |
Sisci D, Middea E, Morelli C, et al (2010). -Estradiol enhances 5 integrin subunit gene expression through ER -Sp1 interaction and reduces cell motility and invasion of ERα-positive breast cancer cells. Breast Cancer Res Treat, 124, 63-77.
DOI
|
28 |
Takei Y, Assenberg M, Tsujimoto G, Laskey R (2002). The MCM3 acetylase MCM3AP inhibits initiation, but not elongation, of DNA replication via interaction with MCM3. J Biol Chem, 277, 43121-5.
DOI
|
29 |
Van Riggelen J, Müller J, Otto T, et al (2010). The interaction between Myc and Miz1 is required to antagonize - dependent autocrine signaling during lymphoma formation and maintenance. Genes Dev, 24, 1281-94.
DOI
|
30 |
Vyhlidal C, Samudio I, Kladde M , Safe S (2000). Transcriptional activation of transforming growth factor alpha by estradiol: requirement for both a GC-rich site and an estrogen response element half-site. J Mol Endocrinol, 24, 329-38.
DOI
|
31 |
Wang Y, Liu S, Zhang G, et al (2005). Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo. Breast Cancer Res, 7, R220-8.
DOI
|
32 |
Yin P, Lin Z, Cheng YH, et al (2007). Progesterone receptor regulates Bcl-2 gene expression through direct binding to its promoter region in uterine leiomyoma cells. J Clin Endocrinol Metab, 92, 4459-66.
DOI
|
33 |
Wernicke S, Rasche F (2006). FANMOD: a tool for fast network motif detection. Bioinformatics, 22, 1152-3.
DOI
|
34 |
Wiercinska E, Naber HPH, Pardali E, et al (2011). The TGF- / Smad pathway induces breast cancer cell invasion through the up-regulation of matrix metalloproteinase 2 and 9 in a spheroid invasion model system. Breast Cancer Res Treat, 128, 657-66.
DOI
ScienceOn
|
35 |
Yager JD, Davidson NE (2006). Estrogen carcinogenesis in breast cancer. New Engl J Med, 354, 270-82.
DOI
|
36 |
Zhao Y, Han W, Li Q, et al (2005). Mechanism of transcriptional regulation of LRP16 gene expression by 17- estradiol in MCF-7 human breast cancer cells. J Mol Endocrinol, 34, 77-89.
DOI
|